These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11700578)

  • 21. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond premenstrual syndrome.
    Gupta S
    Time; 2002 Jun; 159(22):83. PubMed ID: 12066466
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
    Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selections from current literature. Treatments for premenstrual dysphoric disorder.
    Carr M
    Fam Pract; 2001 Dec; 18(6):644-6. PubMed ID: 11739355
    [No Abstract]   [Full Text] [Related]  

  • 28. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
    Med Lett Drugs Ther; 2001 Jan; 43(1096):5-6. PubMed ID: 11177220
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
    Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro.
    Lass-Flörl C; Ledochowski M; Fuchs D; Speth C; Kacani L; Dierich MP; Fuchs A; Würzner R
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):11-5. PubMed ID: 12589952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.
    Yonkers KA; Altemus M; Gilstad-Hayden K; Kornstein SG; Gueorguieva R
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):320-325. PubMed ID: 37212651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of sertraline and its clinical applications in psychiatric disorders.
    McRae AL; Brady KT
    Expert Opin Pharmacother; 2001 May; 2(5):883-92. PubMed ID: 11336629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
    Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
    J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
    Rendas-Baum R; Yang M; Gricar J; Wallenstein GV
    Appl Health Econ Health Policy; 2010; 8(2):129-40. PubMed ID: 20175591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.